Sosyal kuruluşlar için hibeler ve destekler

DoW Spinal Cord Injury, Clinical Translation Research Award

Amerika Birleşik Devletleri · US

Kimler başvurabilir Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Translation Research Award (CTRA) supports high-impact, new, or emerging clinical research that requires additional preliminary studies, such as feasibility, pilot, or optimization, to prepare for future larger-scale clinical trials or implementation. Primary objectives of this mechanism include: • Accelerating the translation of current and emerging techniques or interventions into clinical use by addressing specific barrier(s) to clinical success for the purpose of de-risking or informing the design of definitive trials. • Identifying the most effective diagnosis, treatment and rehabilitation options to support critical decision-making for patients, clinicians, care partners and policymakers. Distinctive Features: • This funding opportunity contains an Early-Career Partnership Option, which allows for two principal investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn. • Applications to this funding opportunity must name at least two spinal cord injury (SCI) community partners who will provide advice and consultation throughout the planning and implementation of the research project.

DoW Spinal Cord Injury, Investigator-Initiated Research Award

Amerika Birleşik Devletleri · US

Kimler başvurabilir Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Investigator-Initiated Research Award (IIRA) supports studies that have the potential to make an important contribution to spinal cord injury (SCI) research, patient care and/or quality of life. May focus on any phase of research from basic through translational science, though studies that focus solely on identifying intervention targets are discouraged. Distinctive Features: • This funding opportunity contains an Early-Career Partnership Option, which allows for two Principal Investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.

ROSES 2025: C.2 Solar System Science

Amerika Birleşik Devletleri · US

Kimler başvurabilir Others (see text field entitled "Additional Information on Eligibility" for clarification)

This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to resubmissions and duplicate proposal avoidance, see the program element text and appropriate overview appendix (e.g., B.1 or C.1). The date shown of 8/1/2026 is the last day that proposals may be submitted subject to the ROSES-25 rules and the current GCAM. The ROSES-26 version of this program element is planned to overlap with this ROSES-25 version by a few weeks, allowing continuous submission of proposals across ROSES years. NOTICE: Updated July 21, 2026. The Anticipated Award Start Date for last submissions in Table C.2-1 in Section 3.1 has been updated. The requirements for Biographical Sketches and Current and Pending Support in Section 3.5 have been updated, as have the Expected program budget for first year of new awards and Number of new awards pending adequate proposals of merit in Section 6. New text is in bold and deleted text is struck through. NOTICE: Research security training required starting August 5, 2026. All PIs and any Co-Is that would spend ≥ 10% time on a proposed grants or cooperative agreements must certify they have taken research security training. NASA will be satisfied with the four online research security training modules on the National Science Foundation's (NSF) Research Security Training website at https://www.nsf.gov/research-security/training or the SECURE Center condensed version of the four modules at https://www.secure-center.org/ctm NOTICE: Amended July 2, 2026. Table C.2-1: Submission and Review Dates in Section 3.1 has been updated and a new row with a new final cut-off date of November 12, 2026, has been added. In addition, this amendment reminds proposers of two important upcoming process changes: Potential proposers are reminded in Section 3.1 that for any proposal for federal assistance submitted > August 5, 2026, PIs and any Co-Is that would spend > 10% time on a proposed grants or cooperative agreements must certify they have taken research security training. NASA will be satisfied with the four online research security training modules on the National Science Foundation’s (NSF) Research Security Training website at https://www.nsf.gov/research-security/training or the SECURE Center condensed version of the four modules at https://www.secure-center.org/ctm The Summary of Requirements for Expertise and Resources Not Anonymized Document in Section 3.5 was updated to indicate that biographical sketches and current and pending support documents submitted after September 1, 2026 must use the NASA-specific Science Experts Network Curriculum Vitae (SciENcv) format found at https://www.ncbi.nlm.nih.gov/sciencv/ per Grant Notice 26-01 . NOTICE: Amended, January 22, 2026. Table C.2-1: Submission and Review Dates in Section 3.1 has been updated and a new final row with a cutoff date of August 1, 2026, has been added. Also, the expected budget and number of new awards in Section 4 have been increased. New text is in bold and deleted text is struck through. NOTICE: Corrected September 9, 2025. NASEM Astrobiology Strategy citation was corrected to 2019 (see Section 1.1.3), reference to the anonymized Table of Work Effort was added to Section 3.2, and HEC request is not included in anonymized proposal (see Section 3.5). New text is in bold and deleted text is struck through. NOTICE: ROSES-25 Amendment 7 makes the following changes to C.1 the Planetary Research Overview: It establishes funding threshold and submission requirements for substantial instrument or equipment requests (Section 3.11), removes the estimated page limit for pilot studies (Section 3.4) and clarifies text on use of spacecraft mission data (Section 3.5). New text is in bold and deleted text is struck through. A Planetary Science Overview FAQ has been posted under other documents on NSPIRES pages for all of Appendix C. NOTICE: Amended August 1, 2025. This amendment makes several changes: It establishes that the anonymized Table of Work Effort and references are outside of the 5-page S/T/M section (see Section 3.2), removes an exclusion regarding data archiving (see Section 2.1), changes the first proposal submission cut-off date for inclusion in the Winter 2025 review to September 15, 2025, changes the second estimated review date to Spring 2026 (see Table C.2-1 in Section 3.1), and removes the HEC requirement in the S/T/M as it appears as a cover page question, see Section 3.2. New text is in bold and deleted text is struck through . This synopsis is a generic summary that is posted for each of the many individual "program elements" in NASA’s Research Opportunities in Space and Earth Sciences (ROSES) – 2025 solicitation. For specific information on this particular program element download and read the PDF of the text of this program element by going to Tables 2 or 3 of ROSES at https://solicitation.nasaprs.com/ROSES2025table2 and https://solicitation.nasaprs.com/ROSES2025table3 , respectively, click the title of the program element of interest, a hypertext link will take you to a page for that particular program element. On that page, on the right side under "Announcement Documents" the link on the bottom will be to the PDF of the text of the call for proposals. For example, if one were interested in the Solar System Science program (NNH25ZDA001N-SCUBED) one would follow the link to the NSPIRES page for that program element and then to read the text of the call one would click on “C.2 Solar System Science (.pdf)” to download the text of the call. If one wanted to set it into the context of the goals, objectives and know the default rules for all elements within Appendix C, the planetary science division, one might download and read “ C.1 Planetary Science Research Program Overview (.pdf) ” from that same page. While the letters and numbers are different for each element within ROSES (A.10, B.3, etc.) the basic configuration is always the same, e.g., the letter indicates the Science Division (A is Earth Science, B is Heliophysics etc.) and whatever the letter, #1 is always the division overview. In 2025, most program elements will be set up for application via Grants.gov only if requested at least 30 days in advance of the due date. For more on Grants.gov submissions see Section IV(b)v of the ROSES Summary of Solicitation, that may be found at https://solicitation.nasaprs.com/ROSES2025 . The National Aeronautics and Space Administration (NASA) Science Mission Directorate (SMD) released its annual omnibus Research Announcement (NRA), Research Opportunities in Space and Earth Sciences (ROSES) – 2025 (OMB Approval Number 2700-0092, CFDA Number 43.001) on February 21, 2025. In this case "omnibus" means that this NRA has many individual program elements, each with its own due dates and topics. All together these cover the wide range of basic and applied supporting research and technology supported by SMD. Awards will be made as grants, cooperative agreements, or contracts depending on the nature of the work proposed. However, most extramural research awards deriving from ROSES will be grants, and many program elements of ROSES specifically exclude contracts, because contracts would not be appropriate for the nature of the work solicited. Funded Co-Is at government labs will receive inter- or intra-agency transfers . The typical period of performance for an award is three years, but some programs may allow up to five years and others specify shorter periods. In most cases, organizations of every type, Government and private, for profit and not-for-profit, domestic and foreign (with some caveats), may submit proposals without restriction on teaming arrangements. Tables listing the program elements and due dates (Tables 2 and 3 ), a table that provides a very top level summary of proposal contents ( Table 1 ), and the full text of the ROSES-2025 "Summary of Solicitation", may all be found NSPIRES at https://solicitation.nasaprs.com/ROSES2025 . Frequently asked questions for ROSES are posted at http://science.nasa.gov/researchers/sara/faqs . Questions concerning specific program elements should be directed to the point(s) of contact for that particular element, who may be found either at the end of the individual program element in the summary table of key information or on the web list of topics and points of contact at: http://science.nasa.gov/researchers/sara/program-officers-list . General questions concerning ROSES-2025 may be directed to the office of the SMD Deputy Associate Administrator for Research at sara@nasa.gov . Not all program elements are known at the time of the release of ROSES. To be informed of new program elements or amendments to this NRA, proposers may subscribe to: (1) The SMD mailing lists (by logging in at http://nspires.nasaprs.com and checking the appropriate boxes under "Account Management" and "Email Subscriptions"), (2) The ROSES-2025 blog feed for amendments, clarifications, and corrections to at https://science.nasa.gov/researchers/solicitations/roses-2025/ , and (3) The ROSES-2025 due date Google calendars (one for each science division). Instructions are at https://science.nasa.gov/researchers/sara/library-and-useful-links (link from the words due date calendar).

Convocatoria para el otorgamiento de subvenciones a los desplazamientos de los equipos y deportistas de Arona por participar en competiciones oficiales para la temporada 2026.

LOCAL - ARONA - ORGANISMO AUTÓNOMO DE DEPORTES ·

Servicios Sociales y Promoción Social

Dönem: 3/8/2026 – —

CONVOCATORIA DE AYUDAS MUNICIPALES PARA SUMINISTROS MÍNIMOS VITALES DEL AYUNTAMIENTO DE FUENLABRADA DE LOS MONTES, EJERCICIO 2026

LOCAL - FUENLABRADA DE LOS MONTES - AYUNTAMIENTO DE FUENLABRADA DE LOS MONTES ·

Servicios Sociales y Promoción Social

Dönem: 1/6/2026 – —

Acuerdo de la Junta de Gobierno nº 59/26 de 24 de abril de 2026, por el que se convocan subvenciones a las Organizaciones Profesionales Agrarias (OPAS) de Valladolid para la realizacion de actividades o elaboracion de estudios sobre el sector agrario

LOCAL - DIPUTACIÓN PROV. DE VALLADOLID - DIPUTACIÓN PROVINCIAL DE VALLADOLID ·

Agricultura, Pesca y Alimentación

Dönem: 1/1/2026 – —

Ayudas R-Activa 2026 destinadas a icentivar la creación, consolidación y crecimientos de empresas localizadas en el municipio de l'Olleria.

LOCAL - OLLERIA, L' - AYUNTAMIENTO DE OLLERIA, L' ·

Fomento del Empleo

onvocatoria de Premios a Trabajos Fin de Grado, Trabajos de fin de Máster y Trabajos Fin de Grado nivel MECES 3 de la Cátedra institucional de transporte sensible a la demanda en CLM de la Consejería de Fomento de la JCCM y la UCLM. Cursos 24-25 y 25-26

OTROS - UNIVERSIDAD DE CASTILLA-LA MANCHA ·

Educación

Dönem: 9/5/2026 – —

Convocatoria de Ayudas de Emergencia Social del año 2026

LOCAL - USANSOLO - AYUNTAMIENTO DE USANSOLO ·

Servicios Sociales y Promoción Social

Dönem: 1/4/2026 – —

RENOVACIÓN DE INSTALACIONES TÉRMICAS 2026

LOCAL - MADRID - ÁREA DE GOBIERNO DE URBANISMO, MEDIO AMBIENTE Y MOVILIDAD ·

Industria y Energía

Dönem: 20/4/2026 – —

2ª Convocatoria de Premios a Trabajos Fin de Grado y Trabajos de fin de Máster del Aula para la Transición Energética y Mundo Rural (UCLM-MOEVE). (Edición Curso 2025-2026)

OTROS - UNIVERSIDAD DE CASTILLA-LA MANCHA ·

Educación

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

Amerika Birleşik Devletleri · US

Kimler başvurabilir Small businesses · Public housing authorities/Indian housing authorities · Independent school districts · County governments · For profit organizations other than small businesses · Public and State controlled institutions of higher education · Native American tribal governments (Federally recognized) · Private institutions of higher education · State governments · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Special district governments

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated mid-phase clinical trials of natural products(i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. All applications submitted under this NOFO must be supported by sufficient preliminary data demonstrating bioavailability (if applicable) and documentation that the natural product produces a reproducible and measurable impact on target engagement (i.e., measure of the mechanism of action). Only in cases when it is not possible/practical to measure target engagement in the patient population of interest or when there is a fundamental understanding of the products mechanism of action will this preliminary data requirement be waived. Applications submitted to this NOFO should propose a mid-phase clinical trial to do the following: determine the optimal dose or formulation of a given natural product for use in a future multi-site efficacy trial; or determine which patient phenotypes will be responders versus non-responders to the natural product to inform inclusion/exclusion criteria of a future efficacy trial. Clinical trials submitted under this NOFO are expected to be hypothesis based, milestone-driven, and directly related to the research priorities and mission of NCCIH. This NOFO will not support single-site or multi-site efficacy or effectiveness trials, nor will it support trials to test natural products for the treatment or prevention of cancer. Applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NO

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Amerika Birleşik Devletleri · US

Kimler başvurabilir For profit organizations other than small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · County governments · Independent school districts · Native American tribal organizations (other than Federally recognized tribal governments) · State governments · Private institutions of higher education · Public and State controlled institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Special district governments · City or township governments · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as dietary supplements), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. Under this NOFO, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. This NOFO will provide up to three years (R61 phase) of support for milestone-driven testing of pharmacokinetics, bioavailability, and assessment of the natural products effect (i.e., measure of mechanism of action) when used by humans on a specified target measure. If milestones in the R61 phase are achieved, up to 3 years of additional support (R33 phase) may be awarded to replicate the impact of the natural product on target engagement(s) when used by humans and assess whether there is an association between the degree of the impact on the target engagement and clinical outcomes in a participant population. Applications are encouraged to design R33 studies to determine how to optimize the impact of the natural product on the target engagement by optimizing the delivery of the natural product through examination of different doses or formulations. In addition, applications can be designed to combine the natural product with another treatment approach that is known to impact the same target engagement measure; or study the impact of the natural product in a population that is more responsive,

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Amerika Birleşik Devletleri · US

Kimler başvurabilir Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public housing authorities/Indian housing authorities · Native American tribal governments (Federally recognized) · Private institutions of higher education · Small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · State governments · City or township governments · For profit organizations other than small businesses · Independent school districts · Special district governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Public and State controlled institutions of higher education

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. Under this NOFO, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. This NOFO will provide up to 3 years support for studies to replicate the impact of the natural product on target engagement when used by humans, and assess whether there is an association between the degree of the impact on target engagement and functional or clinical outcomes in a patient population. Applications are encouraged to design studies to determine how to optimize the impact of the natural product on target engagement by optimizing the delivery of the natural product through examination of different doses or formulations. In addition, applications can be designed to combine the natural product with another treatment approach that is known to engage the same target; or study the impact of the natural product in a target population that is more responsive. Clinical trials submitted under this NOFO are expected to be hypothesis based, milestone-driven, and directly related to the research priorities and mission of NCCIH. This R33 funding mechanism is intended to accelerate the translation of emerging basic science findings about natural products into early-stage clinical testing to determine whether continued clinical research is warranted. This NOFO will not support efficacy or effectiveness trials, nor will

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

Amerika Birleşik Devletleri · US

Kimler başvurabilir City or township governments · Public housing authorities/Indian housing authorities · County governments · Public and State controlled institutions of higher education · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · For profit organizations other than small businesses · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · State governments

This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (Scholars) leading to research independence in the area of substance use and substance use disorder research.

Ayudas a centros escolares de Alicante. Plan protección del medio ambiente. Año 2026.

LOCAL - ALICANTE/ALACANT - AYUNTAMIENTO DE ALICANTE/ALACANT ·

Educación

PRESTACIONES ECONÓMICAS INDIVIDUALIZADAS DE EMERGENCIA SOCIAL PARA EL EJERCICIO 2026

LOCAL - SEGORBE - AYUNTAMIENTO DE SEGORBE ·

Servicios Sociales y Promoción Social

Resolución de 13 de julio de 2026 de la Vicerrectora de Formación Permanente y Extensión Universitaria de la Universidad de La Rioja por la que se convocan ayudas de bolsas de viaje para profesorado sustituto (ABOVIF). Convocatoria 2026.

OTROS - UNIVERSIDAD DE LA RIOJA ·

Educación

SUBVENCIONES PARA EL SOPORTE AL DEPORTE FEDERADO Y A LA PROMOCIÓN DEPORTIVA

LOCAL - DIPUTACIÓN PROV. DE TARRAGONA - DIPUTACIÓN PROVINCIAL DE TARRAGONA ·

Cultura

SUBVENCIÓN DEPORTISTAS NO PROFESIONALES 2026

LOCAL - MOCEJÓN - AYUNTAMIENTO DE MOCEJÓN ·

Sanidad

Dönem: 1/6/2026 – —

CONVOCATORIA DE AYUDAS PARA DERECHOS DE MATRÍCULA PARA CURSOS DE IDIOMAS DEL AULA MENTOR DEL AYUNTAMIENTO DE ALFAFAR - EJERCICIO 2026.

LOCAL - ALFAFAR - AYUNTAMIENTO DE ALFAFAR ·

Educación

CONVOCATORIA DE AYUDAS PARA DERECHOS DE MATRÍCULA PARA CURSOS DE AULA MENTOR DEL AYUNTAMIENTO DE ALFAFAR - EJERCICIO 2026.

LOCAL - ALFAFAR - AYUNTAMIENTO DE ALFAFAR ·

Educación

Convocatoria de subvenciones para el fomento del empleo y la contratación laboral del Ayuntamiento de Albacete 2026.

LOCAL - ALBACETE - AYUNTAMIENTO DE ALBACETE ·

Desempleo

Programa de subvenciones a entidades deportivas de la provincia, sin ánimo de lucro, para el desarrollo de eventos deportivos de competición oficial en el territorio provincial de A Coruña durante o ano 2026. (FO103E/2026)

LOCAL - DIPUTACIÓN PROV. DE A CORUÑA - DIPUTACIÓN PROVINCIAL DE CORUÑA, A ·

Otras actuaciones de carácter económico